Top

Published in:

01-04-2017 | Commentary

Photobiomodulation therapy: management of mucosal necrosis of the oropharynx in previously treated head and neck cancer patients

Authors: Joel B. Epstein, Paul Y. Song, Allen S. Ho, Babak Larian, Arash Asher, Rene-Jean Bensadoun

Published in: Supportive Care in Cancer | Issue 4/2017

Abstract

Necrosis of the oral mucosa following head and neck cancer radiation therapy presents considerable clinical management challenges. We report three cases of symptomatic persisting oral ulcerations where the addition of photobiomodulation therapy resulted in a rapid resolution of the oral lesions and in patient symptoms. These cases suggest that photobiomodulation may represent an adjunct to care of these difficult to manage complications in oncology.

Pereira AN, Eduardo C d P, Matson E, Marques MM (2002) Effect of low-power laser irradiation on cell growth and procollagen synthesis of cultured fibroblasts. Lasers Surg Med 31:263–267CrossRef

Merli LA d S, dos Santos MTBR, Genovese WJ, Faloppa F (2005) Effect of low-intensity laser irradiation on the process of bone repair. Photomed Laser Surg 23:212–215CrossRef

Saygun I, Nizam N, Ural A, Serdar MA, Avcu F, Tozum TF (2013) Low-level laser irradiation affects the release of basic fibroblast growth factor (bFGF), insulin-like growth factor-1 (IGF-1), and receptor of IGF-1 (IDFBP3) from osteoblasts. Photomed Laser Surg 30:149–154CrossRef

Nissan J, Assif D, Gross ME, Yaffe A, Binderman I (2006) Effect of low intensity laser irradiation on surgically created bony defects in rats. J Oral Rehabil 33:619024CrossRef

Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RT (2016) Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer

Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RT (2016) Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: Part 2: proposed applications and treatment protocols. Support Care Cancer

Epstein JB, Raber-Durlacher JE, Lill M, Linhares YPL, Chang J, Barasch A, Slief RIC, Gueke M, Zecha JAM, Milstein DMJ, Tzachinis D (2016) Photobiomodulation therapy in the management of chronic oral graft-versus-host-disease. Support Care Cancer

Romeo U, Galanakis A, Marias C et al (2011) Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: preliminary results. Photomed Laser Surg 29:447–452CrossRef

Vescovi P, Merigo E, Manfredi M et al (2008) Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Photomed Laser Surg 26:37–46CrossRef

10.

Loumanen M, Alaluusua S (2012) Treatment of bisphosphonate-induced osteonecrosis of the jaws with Nd:YAG laser biostimulation. Lasers Med Sci 27:251–255CrossRef

11.

Da Guarda MG, Paraguassu GM, Cerqueira NS, Cury PR, Farias JG et al (2013) Laser GaAIAs (860 nm) photobiomodulation for the treatment of bisphosphonate-induced osteonecrosis of the jaw. Photomed Laser Surg 30:293–297CrossRef

12.

Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P (2011) Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Int J Oral Maxillofac Surg 40:277–284CrossRef

13.

Karu T, Pyatibrat L, Kalendo G (1995) Irradiation with He-Ne laser increases ATP level in cells cultivated in vitro. J Photochem Photobiol B 27(3):219–223CrossRef

14.

Silfvast WT (2004) Laser Fundamentals, 2nd edn. Cambridge University Press, Cambridge, pp. 23–37CrossRef

15.

Peplow PV, Chung T-Y, Baxter GD (2010) Laser photobiomodulation of proliferation of cells in culture: a review of human and animal studies. Photomed Laser Surg 28:S3–40CrossRef

16.

Deigelmann RF, Evans MC (2004) Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9:283–289CrossRef

17.

Huang YY, Sharma SK, Carroll J, Hamblin MR (2011) Biphasic dose response in low level light therapy—an update. Dose-Response 9:602–608CrossRef

18.

Chen CH, Hung HS, Hsu SH (2008) Low-energy laser irradiation increases endothelial cell proliferation, migration, and eNOS gene expression possibly via PI3K signal pathway. Lasers in Surg Med 40:46–54CrossRef

19.

Kimura H, Esumi H (2003) Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochemica Polonica 50:49–60

20.

Gao X, Xing D (2009) Molecular mechanisms of cell proliferation induced by low power laser irradiation. J Biomed Sci 16:1–16CrossRef

21.

Mirsky N, Krispel Y, Shoshany Y, Maltz L, Oron U (2002) Promotion of angiogenesis by low energy laser irradiation. Antioxidant Redox Signal 4:785–790CrossRef

22.

Danno K, Mori N, Toda KI, Kobayashi T, Utani A (2001) Near-infrared irradiation stimulates cutaneous wound repair: laboratory experiments on possible mechanisms. Photodermatol photoimmun photomed 17:261–265CrossRef

23.

Stadler I, Lanzafame RJ, Evans R, Narayan V, Dailey B, Buehner N, Naim JO (2001) 830-nm irradiation increases the wound tensile strength in a diabetic murine model. Lasers Surg Med 28:220–226CrossRef

Title: Photobiomodulation therapy: management of mucosal necrosis of the oropharynx in previously treated head and neck cancer patients
Authors: Joel B. Epstein
Paul Y. Song
Allen S. Ho
Babak Larian
Arash Asher
Rene-Jean Bensadoun
Publication date: 01-04-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 4/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3525-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2017

Fear of cancer recurrence and physical well-being among Chinese cancer survivors: the role of conscientiousness, positive reappraisal and hopelessness

RETRACTED ARTICLE: Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study

Prevalence and risk factors of adhesive capsulitis of the shoulder after breast cancer treatment

Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and coping

Predictors of response to corticosteroids for dyspnea in advanced cancer patients: a preliminary multicenter prospective observational study

Review of yoga therapy during cancer treatment

Keynote webinar | Spotlight on antibody–drug conjugates in cancer